Schmertzler Michael's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Sep 18, 2026
- Accession no.
- 0001288952-26-000012
- Filed
- Sep 18, 2026, 5:20 PM ET
- Trade date
- Sep 16-17, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $1.35M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schmertzler MichaelCIK 0001288952 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Common Stock | SSaleDisposed | −2,994 | $66.58F2 | −$199,340.52 | 1,313,600 | Indirect | |
| Sep 16, 2026 | Common Stock | SSaleDisposed | −7,006 | $67.35F4 | −$471,854.1 | 1,306,594 | Indirect | |
| Sep 17, 2026 | Common Stock | SSaleDisposed | −9,624 | $67.83F5 | −$652,795.92 | 1,296,970 | Indirect | |
| Sep 17, 2026 | Common Stock | SSaleDisposed | −376 | $68.45F6 | −$25,737.2 | 1,296,594 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $65.99 to $66.96 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $66.99 to $67.72 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $67.27 to $68.10 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.35 to $68.84 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.